Edition:
United States

Rexahn Pharmaceuticals Inc (RNN)

RNN on American Stock Exchange

2.41USD
21 Sep 2017
Change (% chg)

$0.08 (+3.43%)
Prev Close
$2.33
Open
$2.35
Day's High
$2.42
Day's Low
$2.33
Volume
169,185
Avg. Vol
261,752
52-wk High
$7.10
52-wk Low
$1.27

Select another date:

Wed, Aug 30 2017

BRIEF-Rexahn Pharmaceuticals receives new U.S. patent for Supinoxin

* Rexahn Pharmaceuticals receives new U.S. patent for Supinoxin Source text for Eikon: Further company coverage:

BRIEF-Rexahn Pharmaceuticals reports Q2 earnings per share $0.04

* Rexahn Pharmaceuticals reports second quarter 2017 financial and operational results

BRIEF-Rexahn pharmaceuticals receives notice of allowance for a new u.s. Patent covering the use of rx-3117

* Rexahn pharmaceuticals receives notice of allowance for a new u.s. Patent covering the use of rx-3117

BRIEF-Rexahn Pharmaceuticals announces $10 mln registered direct offering

* Rexahn Pharmaceuticals Inc - net proceeds of offering will be used for further development of rexahn's lead clinical programs,

BRIEF-Rexahn Pharmaceuticals files for mixed shelf offering of up to $150 mln‍​

* Rexahn Pharmaceuticals files for mixed shelf offering of up to $150 million - sec filing‍​ Source text (http://bit.ly/2s4PKc4) Further company coverage:

BRIEF-Rexahn Pharmaceuticals reports Q1 loss per share $0.09

* Rexahn Pharmaceuticals reports first quarter 2017 financial results and provides corporate update

BRIEF-Rexahn announces 1-for-10 reverse stock split

* Expects that reverse stock split will be effective on May 5, 2017 Source text for Eikon: Further company coverage:

Select another date: